Skip to main content

Our Latest Data

Event

OPTIONS XII for the Control of Influenza

Brisbane, Australia | September 2024

ASM MICROBE

Atlanta, GA | June 2024

Manuscript

European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

Barcelona, Spain | April 2024

American Association for Cancer Research (AACR) Annual Meeting

San Diego, CA | April 2024

ESMO Immuno-Oncology (IO) Annual Congress

Geneva, Switzerland | December 2023

  • Discovery of a Novel, Dual CD73 & PD-1 Targeting Multispecific Drug Fc-Conjugate (DFC) for the Treatment of Cancer [Poster] [Abstract]
  • Discovery of CBO421, a First-in-Class Drug Fc-Conjugate (DFC), Targeting CD73 in Cancer [Poster] [Abstract]

Society for Immunotherapy of Cancer (SITC)

San Diego, CA | November 2023

  • Discovery of CBO421, a First-in-Class Drug Fc-conjugate (DFC), Targeting CD73 in Cancer [Poster] [Abstract]

IDWeek

Boston, MA | October 2023

Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit

Boston, MA | June 2023

International Society for Influenza and Other Respiratory Virus Diseases (ISIRV)

Seattle, WA | May 2023

ESMO Targeted Anticancer Therapies

Paris, France | March 2023

ESWI

Keynote Lecture | December 2020

ESWI

VIRTUAL | December 2020

IDWeek

VIRTUAL | October 2020

ECCMID

Abstract Book | April 2020

Manuscript

IDWeek

Washington, D.C. | October 2019

Options X

Singapore | August 2019

ASM Microbe

San Francisco, CA | June 2019

ECCMID

Amsterdam | April 2019